Skip to content

Clinical trials

Completed Essential Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Status: Completed Country / region: United States Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20075
20085
20092
20103
20111
20122
20132
20141
20153
20161
20171
20183
20191
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Novartis Pharmaceuticals5
Novartis3
PhaseBio Pharmaceuticals Inc.2
Roxane Laboratories2
University of Texas Southwestern Medical Center2
Wake Forest University Health Sciences2
Arbor Pharmaceuticals, Inc.1
Bayer1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension37
Hypertension21
Cardiovascular Diseases11
Vascular Diseases3
Hyperlipidemias2
Obesity2
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Hypertrophy, Left Ventricular1
Metabolic Syndrome1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.